VT107
Modify Date: 2024-01-08 18:20:55
VT107 structure
|
Common Name | VT107 | ||
|---|---|---|---|---|
| CAS Number | 2417718-63-7 | Molecular Weight | 435.44 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H20F3N3O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of VT107VT-107, as an analogous to VT104, is a potent pan-TEAD auto-palmitoylation inhibitor. VT-107 can be used for the research of cancer[1]. |
| Name | VT107 |
|---|
| Description | VT-107, as an analogous to VT104, is a potent pan-TEAD auto-palmitoylation inhibitor. VT-107 can be used for the research of cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
TEAD[1] |
| In Vitro | VT107 (3 μmol/L; 20 hours; HEK293T cells) inhibits palmitoylation of both endogenous TEAD1 and TEAD3 proteins and is the most potent at blocking the palmitoylation of endogenous TEAD4 protein[1]. VT107 prevents palmitoylation of the TEAD1 protein. VT107 is slightly more potent than VT104 on TEAD2 and TEAD4. VT107 results in the disappearance of palmitoylated TEAD1 with a concomitant increase in unpalmitoylated TEAD1. VT107 decreases the levels of palmitoylated TEAD3 and TEAD4 and increases the levels of unpalmitoylated TEAD3 and TEAD4. VT107 blocks YAP and TAZ interaction with both TEAD1 and TEAD4. VT107 potently inhibits the proliferation of NF2-mutated/deficient cell lines[1]. Western Blot Analysis[1] Cell Line: HEK293T cells Concentration: 3 μmol/L Incubation Time: 20 hours Result: Inhibited palmitoylation of both endogenous TEAD1 and TEAD3 proteins and was the most potent at blocking the palmitoylation of endogenous TEAD4 protein. |
| In Vivo | VT107 (10 mg/kg; p.o.) is a enantiomer analogous to VT104[1]. Animal Model: Mouse[1] Dosage: 10 mg/kg (Pharmacokinetic Analysis) Administration: P.o. Result: Enantiomer analogous to VT104. |
| References |
| Molecular Formula | C25H20F3N3O |
|---|---|
| Molecular Weight | 435.44 |